PROSPECTS FOR SEARCHING MULTITARGET TOPOISOMERASE INHIBITORS WITH ANTITUMOR PROPERTIES
Purpose of research: to identify the prospects of search for new antitumor non-camptothecin inhibitors of topoisomerase I/II among the various chemical compounds based on the analysis of side effects.Material and Methods. The analysis included 65 relevant literature sources for 2002–2018 years, foun...
Main Authors: | M. I. Treshchalin, E. V. Neborak, H. M. Treshalina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Tomsk National Research Medical Center of the Russian Academy of Sciences
2019-09-01
|
Series: | Sibirskij Onkologičeskij Žurnal |
Subjects: | |
Online Access: | https://www.siboncoj.ru/jour/article/view/1142 |
Similar Items
-
Subchronic Toxicity Study of Oral Anthrafuran on Rabbits
by: Michael I. Treshchalin, et al.
Published: (2021-09-01) -
Experimental Evaluation of Anticancer Efficiency and Acute Toxicity of Anthrafuran for Oral Administration
by: Andrey E. Shchekotikhin, et al.
Published: (2020-04-01) -
Evodiamine-inspired dual inhibitors of histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) with potent antitumor activity
by: Yahui Huang, et al.
Published: (2020-07-01) -
DNA topoisomerases as molecular targets for anticancer drugs
by: Kamila Buzun, et al.
Published: (2020-01-01) -
The antitumor activity of CYB-L10, a human topoisomerase IB catalytic inhibitor
by: Qian Yu, et al.
Published: (2019-01-01)